CBD Life Sciences Inc. (CBDL)
Announces Grand View Research Report Findings on High - Growth CBD
Equine Market, Aiming to Drive Unprecedented Shareholder
Value
The global CBD pet care market,
which includes products for animals like dogs, cats, and horses,
was valued at approximately $125 million in 2020 and is expected to
grow at a compound annual growth rate (CAGR) of 40.3% from 2021 to
2028.
SCOTTSDALE, AZ -- October 29, 2024 --
InvestorsHub NewsWire -- CBD Life Sciences Inc.
(CBDL),
an innovative leader in the CBD industry, is positioning itself to
capitalize on the rapidly expanding CBD pet care market with a bold
entry into equine products. With the market expected to soar at a
40.3% CAGR through 2028, CBDL is taking a strategic approach to an
underserved niche within this $125 million industry. By focusing on
high-demand equine health products, CBDL aims to set itself apart
from competitors while delivering maximum value to its
investors.
CBDL's equine-specific products offer a powerful
blend of natural wellness and therapeutic benefits, answering the
demand from pet owners who increasingly seek alternative health
solutions for their animals. Unlike the crowded household pet
sector, the equine segment remains a relatively untapped market in
the CBD space, allowing CBDL to leverage its proprietary
formulations and quality-driven product development to build a
strong market foothold.
"As
a publicly traded company, CBD Life Sciences Inc. has the distinct
advantage of bringing transparency and robust standards to a
burgeoning industry," stated Lisa Nelson, CEO of CBDL. "Our
innovative equine line is positioned to capture meaningful market
share in an area of rapid growth, giving shareholders and investors
a unique investment in a high-demand, low-competition
sector."
This
equine-focused strategy is supported by growing consumer demand for
safe, effective, and scientifically backed products that improve
animal wellness. CBDL's equine formulations, meticulously crafted
to deliver both physical and psychological support, have been
developed by veterinary experts to address the specific needs of
horses, with benefits that include reducing inflammation, improving
recovery times, and enhancing overall well-being.
The
decision to target equine products also aligns with broader market
trends toward natural and integrative health solutions for pets, as
highlighted in the Grand View Research report on CBD Pet Market
Size, Share & Trends Analysis. According to the report, pet
owners are increasingly turning to CBD-based products to promote
the wellness of their animals, which not only validates CBDL's
direction but also suggests high growth potential for the brand's
expanding pet care line.
Positioned to Benefit
Shareholders with High Growth and Market Visibility
With
CBDL's entry into the equine market, the company is poised for
substantial revenue growth, making it an attractive investment
opportunity for shareholders seeking exposure to both the booming
CBD sector and the rising pet care industry. CBDL has demonstrated
a solid track record of revenue increases and product success,
achieving a notable 1405.46% growth since early 2024 across various
product categories. The company's reputation and stability as a
publicly traded entity offer an added layer of security for
shareholders, who stand to benefit as CBDL expands its footprint in
emerging markets.
Grand View Research
Link: https://www.grandviewresearch.com/industry
- analysis/cannabidiol-pet-market
About CBD Life Sciences,
Inc.
CBD
Life Sciences, Inc. (OTC
PINK: CBDL) is a leading innovator in
the CBD and wellness industry, committed to creating high-quality,
scientifically backed products that promote health and well
-
being. From pain relief to overall wellness, CBD Life Sciences
strives to deliver top-tier
solutions that meet the needs of today's
consumers.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR
Contact: cbdvaultaz@gmail.com
Forward-Looking
Statements
Except for the historical information contained
herein, the matters discussed in this press release are
forward-looking statements. Actual results may differ materially
from those described in forward-looking statements and are subject
to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s
filings with OTC Markets, which may identify specific factors that
may cause actual results or events to differ materially from those
described in the forward-looking statements.
Safe Harbor
Statement
This
release includes forward-looking statements, which are based on
certain assumptions and reflects management's current expectations.
These forward-looking statements are subject to a number of risks
and uncertainties that could cause actual results or events to
differ materially from current expectations. Some of these factors
include: general global economic conditions; general industry and
market conditions, sector changes and growth rates; uncertainty as
to whether our strategies and business plans will yield the
expected benefits; increasing competition; availability and cost of
capital; the ability to identify and develop and achieve commercial
success; the level of expenditures necessary to maintain and
improve the quality of services; changes in the economy; changes in
laws and regulations, including codes and standards, intellectual
property rights, and tax matters; or other matters not anticipated;
our ability to secure and maintain strategic relationships and
distribution agreements. The Company disclaims any intention or
obligation to update or revise any forward-looking ability to
secure and maintain strategic relationships and distribution
agreements. The Company disclaims any intention or obligation to
update or revise any
forward-looking statements.
Contact Information
Lisa
Nelson
CEO cbdvaultaz@gmail.com
4802091720
